US firm launches telemedicine platform to support drug product for India
US firm launches telemedicine platform to support respiratory health in India US firm launches telemedicine platform to support respiratory health in India 03 February 2021 | News Source credit: PulmoHeal Mateon Therapeutics, Inc, a US based developer of TGF-β therapeutics for oncology and infectious diseases, has announced that it has launched its artificial intelligence (AI) telemedicine platform for post marketing survey (PMS) to support the launch of its drug product, PulmoHeal TM. TM, rounds out the company’s AI telemedicine solution. The combination of the drug and telemedicine targ...
Source: biospectrumindia.com
